GlobeNews Wire

1053 Articles

Psyence BioMed Announces Approval for Use of PsyLabs Psilocybin Product in Phase IIb Clinical Trial

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq:…

GlobeNews Wire

ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories

Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth…

GlobeNews Wire

Intermap Awarded Malaysian Flood Mapping Program; Indonesia ILASPP Phase 2 Evaluation Period Extended

December 18, 2025 17:30 ET  | Source: Intermap Technologies Malaysian award expands…

GlobeNews Wire

TransAlta Provides Notice to Mothball Sheerness Unit 1

December 18, 2025 17:22 ET  | Source: TransAlta Corporation CALGARY, Alberta, Dec.…

GlobeNews Wire

Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

BOCA RATON, FLA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings,…

GlobeNews Wire

AlphaTON Capital Corp Issues Clarification on Anduril Industries Investment Program

DOVER, DE, Dec. 17, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (NASDAQ:…

GlobeNews Wire

CISO Global Books Over $1.1M in CHECKLIGHT Software Sales –

One of the Nation’s Largest Religious Institutions Renews and Expands via a…

GlobeNews Wire

Peptinovo Biopharma in Collaboration with Chemelectiva Announces Breakthrough Manufacturing Innovation for Targeted Chemotherapy

First-of-its-kind semi-synthetic vitamin E product enables scalable, FDA-compliant production of Peptinovo’s proprietary…

GlobeNews Wire